Polarityte Financial Statements From 2010 to 2024
| PTEDelisted Stock | USD 0.07 0.01 10.29% |
Check Polarityte financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Polarityte's main balance sheet or income statement drivers, such as , as well as many indicators such as . Polarityte financial statements analysis is a perfect complement when working with Polarityte Valuation or Volatility modules.
Polarityte |
Polarityte Company Return On Equity Analysis
Polarityte's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Polarityte Return On Equity | -0.55 |
Most of Polarityte's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Polarityte is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
CompetitionBased on the latest financial disclosure, Polarityte has a Return On Equity of -0.5497. This is 97.71% lower than that of the Biotechnology sector and 98.49% lower than that of the Health Care industry. The return on equity for all United States stocks is 77.32% higher than that of the company.
Polarityte Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Polarityte's current stock value. Our valuation model uses many indicators to compare Polarityte value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Polarityte competition to find correlations between indicators driving Polarityte's intrinsic value. More Info.Polarityte is regarded third in return on equity category among its peers. It is rated below average in return on asset category among its peers . Comparative valuation analysis is a catch-all technique that is used if you cannot value Polarityte by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.About Polarityte Financial Statements
Polarityte stakeholders use historical fundamental indicators, such as Polarityte's revenue or net income, to determine how well the company is positioned to perform in the future. Although Polarityte investors may analyze each financial statement separately, they are all interrelated. For example, changes in Polarityte's assets and liabilities are reflected in the revenues and expenses on Polarityte's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Polarityte. Please read more on our technical analysis and fundamental analysis pages.
PolarityTE, Inc., a clinical stage biotechnology company, develops and commercializes a range of regenerative tissue products and biomaterials for the fields of medicine, biomedical engineering, and material sciences in the United States. The company also develops SkinTE Cryo allows multiple deployments from one original harvest through a cryopreservation process SkinTE point-of-care device to permit the processing and deployment of SkinTE immediately following the initial harvest at the point-of-car PTE 11000, an allogenic, biologically active dressing for use in wound care and aesthetics to accelerate healing of skin and other tissue regeneration products. Polarityte operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 59 people.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.
Other Consideration for investing in Polarityte Stock
If you are still planning to invest in Polarityte check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Polarityte's history and understand the potential risks before investing.
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Transaction History View history of all your transactions and understand their impact on performance |